Terms: = Leukemia AND MITF, WS2A, ENSG00000187098, 4286 AND Diagnosis
3 results:
1. Risk of new malignancies among patients with CLL treated with chemotherapy: results of a Danish population-based study.
da Cunha-Bang C; Rostgaard K; Andersen MA; Rotbain EC; Grønbaek K; Frederiksen H; Niemann CU; Hjalgrim H
Br J Haematol; 2021 Apr; 193(2):339-345. PubMed ID: 33570184
[TBL] [Abstract] [Full Text] [Related]
2. Bone marrow mesenchymal stromal cell (MSC) gene profiling in chronic myeloid leukemia (CML) patients at diagnosis and in deep molecular response induced by tyrosine kinase inhibitors (TKIs).
Aggoune D; Sorel N; Bonnet ML; Goujon JM; Tarte K; Hérault O; Domenech J; Réa D; Legros L; Johnson-Ansa H; Rousselot P; Cayssials E; Guerci-Bresler A; Bennaceur-Griscelli A; Chomel JC; Turhan AG
Leuk Res; 2017 Sep; 60():94-102. PubMed ID: 28772207
[TBL] [Abstract] [Full Text] [Related]
3. Immunohistochemical analysis of novel monoclonal antibody PNL2 and comparison with other melanocyte differentiation markers.
Busam KJ; Kucukgöl D; Sato E; Frosina D; Teruya-Feldstein J; Jungbluth AA
Am J Surg Pathol; 2005 Mar; 29(3):400-6. PubMed ID: 15725810
[TBL] [Abstract] [Full Text] [Related]
